286 related articles for article (PubMed ID: 1400881)
1. Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.
Robinson BM; Friberg RD; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1992 Oct; 75(4):1121-4. PubMed ID: 1400881
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
4. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.
Bowers CY; Reynolds GA; Durham D; Barrera CM; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.
Villas-Boas Weffort RF; Ramos-Dias JC; Chipoch C; Lengyel AM
Metabolism; 1997 Jun; 46(6):706-10. PubMed ID: 9186309
[TBL] [Abstract][Full Text] [Related]
7. On the actions of the growth hormone-releasing hexapeptide, GHRP.
Bowers CY; Sartor AO; Reynolds GA; Badger TM
Endocrinology; 1991 Apr; 128(4):2027-35. PubMed ID: 2004615
[TBL] [Abstract][Full Text] [Related]
8. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
Cordido F; Peñalva A; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
[TBL] [Abstract][Full Text] [Related]
9. Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration.
Ghigo E; Arvat E; Rizzi G; Bellone J; Nicolosi M; Boffano GM; Mucci M; Boghen MF; Camanni F
J Endocrinol Invest; 1994 Mar; 17(3):157-62. PubMed ID: 8051337
[TBL] [Abstract][Full Text] [Related]
10. No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.
Roh SG; He ML; Matsunaga N; Hidaka S; Hidari H
J Anim Sci; 1997 Oct; 75(10):2749-53. PubMed ID: 9331880
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
Malozowski S; Hao EH; Ren SG; Marin G; Liu L; Southers JL; Merriam GR
J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
[TBL] [Abstract][Full Text] [Related]
12. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
Bowers CY; Granda-Ayala R
Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
[TBL] [Abstract][Full Text] [Related]
14. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly.
Alster DK; Bowers CY; Jaffe CA; Ho PJ; Barkan AL
J Clin Endocrinol Metab; 1993 Sep; 77(3):842-5. PubMed ID: 8370708
[TBL] [Abstract][Full Text] [Related]
15. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
16. Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat.
Mallo F; Alvarez CV; Benitez L; Burguera B; Coya R; Casanueva FF; Dieguez C
Neuroendocrinology; 1993; 57(2):247-56. PubMed ID: 8510800
[TBL] [Abstract][Full Text] [Related]
17. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I
Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6.
Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]